Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
LeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares Outstanding
Ratios

Contineum Therapeutics (CTNM) Shares Outstanding (2023 - 2025)

Contineum Therapeutics has reported Shares Outstanding over the past 3 years, most recently at $29.2 million for Q3 2025.

  • Quarterly results put Shares Outstanding at $29.2 million for Q3 2025, up 333.67% from a year ago — trailing twelve months through Sep 2025 was $29.2 million (up 333.67% YoY), and the annual figure for FY2024 was $19.1 million, changed.
  • Shares Outstanding for Q3 2025 was $29.2 million at Contineum Therapeutics, up from $25.9 million in the prior quarter.
  • Over the last five years, Shares Outstanding for CTNM hit a ceiling of $29.2 million in Q3 2025 and a floor of $2.3 million in Q2 2023.
  • Median Shares Outstanding over the past 3 years was $20.9 million (2023), compared with a mean of $19.1 million.
  • Biggest five-year swings in Shares Outstanding: crashed 79.95% in 2024 and later soared 985.02% in 2025.
  • Contineum Therapeutics' Shares Outstanding stood at $2.3 million in 2023, then surged by 720.06% to $19.1 million in 2024, then surged by 52.59% to $29.2 million in 2025.
  • The last three reported values for Shares Outstanding were $29.2 million (Q3 2025), $6.7 million (Q2 2025), and $25.9 million (Q1 2025) per Business Quant data.